en · de · es · fr · pt
sr9009-notes.peptides6608.com › Faq › Sr9009 Background And Receptor Mechanism — Practical Notes

Sr9009 Background And Receptor Mechanism — Practical Notes

By Editorial Desk · published 2025-12-28 · last reviewed 2026-02-09 · Faq

REV-ERB agonist is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.

Last reviewed on 2026-02-09. Where a claim depends on a specific study, the study is described rather than over-claimed.

SR9009 Background and Receptor Mechanism

SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.

SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.

Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.

Regulation, Testing, and Storage

Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.

Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.

Sr9009 at a glance

PropertyValueNotes
Chemical classSynthetic REV-ERB agonistSmall-molecule nuclear receptor ligand
AppearanceOff-white to pale yellow solidTypical for research-grade powder
Solubility classSoluble in DMSO; low water solubilityCommon stock solutions use organic solvent
Typical stock solventDimethyl sulfoxideUsed for laboratory assays
Common analytical methodHPLC with UV or mass detectionUsed for identity and purity checks

Background and Pharmacological Mechanism

SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.

SR9009 is a synthetic small molecule developed as a REV-ERB agonist. It binds to REV-ERBα and REV-ERBβ, nuclear receptors that help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, the compound alters lipid and glucose handling and influences skeletal muscle oxidative capacity. Its exact effects in humans remain largely uncharacterized because controlled clinical trials have not been reported. The molecule is frequently described in preclinical literature as a metabolic modulator.

Research interest in SR9009 grew from studies showing improved running endurance in mice after short treatment periods. Those experiments linked the compound to increased mitochondrial content and fatty acid oxidation in muscle, but the findings come from animal models and specific dosing schedules. Independent replication has been limited, and the pathways connecting REV-ERB activation to exercise performance are still being mapped. Whether similar responses occur in humans is an open question.

Related pages on this site

Background from the literature

=== Central fatigue === Central fatigue is a reduction in the neural drive or nerve-based motor command to working muscles that results in a decline in the force output. It has been suggested that the reduced neural drive during exercise may be a protective mechanism to prevent organ failure if the work was continued at the same intensity. There has been a great deal of interest in the role of serotonergic pathways for several years because its concentration in the brain increases with motor activity. During motor activity, serotonin released in synapses that contact motoneurons promotes muscle contraction. During high level of motor activity, the amount of serotonin released increases and a spillover occurs. Serotonin binds to extrasynaptic receptors located on the axon initial segment of motoneurons with the result that nerve impulse initiation and thereby muscle contraction are inhibited.

==== Bangsamoro ==== In the Bangsamoro Parliament, members of the interim body, known as the Bangsamoro Transition Authority, are nominated by both the Moro Islamic Liberation Front (MILF) and the Philippine government, and appointed by the president of the Philippines.

==== Transcutaneous lower blepharoplasty ==== In transcutaneous lower blepharoplasty, an incision is made just below the eyelashes. This approach allows for removal or repositioning of orbital fat, excision of excess skin, and modification of the orbicularis oculi muscle when necessary. It is typically used in patients with significant skin laxity.

Therapeutic interventions predominantly involve psychotherapy, with dialectical behavior therapy (DBT) and schema therapy being the most effective. Although pharmacotherapy cannot cure BPD, it may be employed to mitigate symptoms, with atypical antipsychotics and selective serotonin reuptake inhibitor (SSRI) antidepressants commonly prescribed. Medications are used cautiously and may have minimal impact on neural function. Due to the high utilization of healthcare resources by people with BPD, up to half may show significant improvement over ten years with appropriate treatment. Estimation of BPD's prevalence varies. In the US, around 1% of the population are diagnosed with it. BPD is more prevalent among adolescents and young adults than elderly, and symptoms may remit with age. The term 'borderline' is debated, as it referred to concepts of borderline insanity and patients on the border between neurosis and psychosis, which are now considered clinically imprecise.

Sources: en.wikipedia.org

Further detail

Overweight Non- Supportive footwear Flat arched feet High arched feet A sudden increase in activity/Overuse Hormone problems Lack of flexibility of the calf, Achilles tendon and the plantar fascia. Connective tissue disorders such as rheumatoid arthritis.

==== Solution and precipitation ==== The diagram above illustrates the point that a precipitate that is not one of the main species in the solution equilibrium may be formed. At pH just below 5.5 the main species present in a 5 μM solution of Al3+ are aluminium hydroxides Al(OH)2+, AlOH+2 and Al13(OH)7+32, but on raising the pH Al(OH)3 precipitates from the solution. This occurs because Al(OH)3 has a very large lattice energy. As the pH rises more and more Al(OH)3 comes out of solution. This is an example of Le Châtelier's principle in action: Increasing the concentration of the hydroxide ion causes more aluminium hydroxide to precipitate, which removes hydroxide from the solution. When the hydroxide concentration becomes sufficiently high the soluble aluminate, Al(OH)−4, is formed. Another common instance where precipitation occurs is when a metal cation interacts with an anionic ligand to form an electrically neutral complex. If the complex is hydrophobic, it will precipitate out of water. This occurs with the nickel ion Ni2+ and dimethylglyoxime, (dmgH2): in this case the lattice energy of the solid is not particularly large, but it greatly exceeds the energy of solvation of the molecule Ni(dmgH)2.

If feather-like structures were indeed widely present among non-avian dinosaurs, the lack of abundant fossil evidence for them may be due to the fact that delicate features like skin and feathers are seldom preserved by fossilization and thus often absent from the fossil record.

Mass spectrometry is an important method for the characterization and sequencing of proteins. The two primary methods for ionization of whole proteins are electrospray ionization (ESI) and matrix-assisted laser desorption/ionization (MALDI). In keeping with the performance and mass range of available mass spectrometers, two approaches are used for characterizing proteins. In the first, intact proteins are ionized by either of the two techniques described above, and then introduced to a mass analyzer. This approach is referred to as "top-down" strategy of protein analysis. The top-down approach however is largely limited to low-throughput single-protein studies. In the second, proteins are enzymatically digested into smaller peptides using proteases such as trypsin or pepsin, either in solution or in gel after electrophoretic separation. Other proteolytic agents are also used. The collection of peptide products are often separated by chromatography prior to introduction to the mass analyzer. When the characteristic pattern of peptides is used for the identification of the protein the method is called peptide mass fingerprinting (PMF), if the identification is performed using the sequence data determined in tandem MS analysis it is called de novo peptide sequencing. These procedures of protein analysis are also referred to as the "bottom-up" approach, and have also been used to analyse the distribution and position of post-translational modifications such as phosphorylation on proteins.

Historically Druzes, by large, sent their children to Protestant schools and accepted an implicit orientation toward Britain. Many of the first graduates of the Syrian Protestant College in Beirut, the forerunner of AUB, were Druze, who over generations maintain an affinity to AUB. At the Catholic schools and universities (such as Notre Dame University–Louaize) in Lebanon, Christian and Druze students study and socialise together. Moreover, many members of the Druze political and cultural elite received their education in Christian institutions. Notable Druze figures who studied at these institutions include Abbas Halabi, Asad Al Faqih, Majid Arslan, Marwan Hamadeh, Manal Abdel Samad, and Kamal Jumblatt, who attended the prestigious Collège Saint Joseph – Antoura. Marriage outside the Druze faith is rare and is strongly discouraged, and Druze can face serious social consequences if he or she converts to another faith to marry a non-Druze. According to Simon Haddad of Notre Dame University–Louaize "if a Druze marries a Christian or Muslim, they could both be ostracized and marginalized by their community, and this could have very serious consequences if the couple works in town". While according to United Nations High Commissioner for Refugees report: "Conversely, a source contacted by the Research Directorate of Canada's Immigration and Refugee Board in September 1998 advised that "there would be no problem for a mixed Druze/Orthodox Christian couple to live a normal life in Lebanon today"".

Sources: en.wikipedia.org

Frequently asked questions

What is SR9009?

SR9009 is a synthetic research compound that acts on REV-ERB nuclear receptors. It is not approved for human use and is sold only as a research chemical. Its effects have been studied mainly in cells and rodents.

How does SR9009 work?

It binds REV-ERB alpha and REV-ERB beta and changes the expression of genes tied to metabolism and circadian rhythm. These changes can affect mitochondria and energy use in animal models. The exact chain from receptor binding to physiological outcome is still being mapped.

Is SR9009 a proven performance enhancer?

No reliable human trials show that SR9009 improves athletic performance. Some rodent studies report endurance changes, but these results are not proof of human benefit. Its use in sport is prohibited, and quality and safety data are lacking.

Is SR9009 legal?

Its legal status depends on the country and intended use. It is not an approved medicine in major jurisdictions. In sport, it is prohibited by anti-doping rules.

Network